Role of hepatic fatty acid:coenzyme a ligases in the metabolism of xenobiotic carboxylic acids

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 10, 1998, Pages 776-782

  Knights, Kathleen M ^a,b  

^a FLINDERS UNIVERSITY   (Australia)

^b FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Arylpropionyl coenzyme A thioesters; Coenzyme A; Drug metabolism; Long chain fatty acid coenzyme A ligase; Xenobiotic carboxylic acids; Xenobiotic coenzyme A thioesters

Indexed keywords

ACETYL COENZYME A SYNTHETASE; ACYL COENZYME A; ARYLPROPIONIC ACID DERIVATIVE; BENZOIC ACID; CARBOXYLIC ACID; CLOFIBRIC ACID; FATTY ACID; IBUPROFEN; LONG CHAIN FATTY ACID COENZYME A LIGASE; PALMITOYL COENZYME A HYDROLASE; SALICYLIC ACID;

ADIPOSE TISSUE; CHROMOSOME 4; DRUG METABOLISM; ENZYME LOCALIZATION; ENZYME SPECIFICITY; FATTY ACID METABOLISM; GENE LOCATION; LIPOGENESIS; LIVER; LIVER MICROSOME; MITOCHONDRION; PEROXISOME; REVIEW; XENOBIOTIC METABOLISM;

EID: 0031663753     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02152.x     Document Type: Review

References (75)

1. Miners JO, Mackenzie PI. Drug glucuronidation in humans. Pharmacol. Ther. 1991; 51: 347-69.
2. Hutt AJ, Caldwell J. Amino acid conjugation. In: Mulder GJ (ed.). Conjugation Reactions in Drug Metabolism: An integrated approach. Taylor and Francis, London. 1990; Ch. 10.
3. Nandi DL, Lucas SV, Webster LT. Benzoyl-coenzyme A glycine N-acyltransferase and phenylacetyl-coenzyme A glycine N-acyltransferase from bovine liver mitochondria. J. Biol Chem. 1979; 254: 7230-7.
4. Mawal YR, Qureshi IA. Purification to homogeneity of mitochondrial acyl CoA:glycine N-acyltransferase from human liver. Biochem. Biophys. Res. Commun. 1994; 205: 1373-9.
5. Fears R. Lipophilic xenobiotic conjugates: The pharmacological and toxicological consequences of the participation of drugs and other foreign compounds as substrates in lipid biosynthesis. Biochem. Pharmacol. 1985; 24: 177-95.
6. Geelen MJH. Medium chain fatty acids as short-term regulators of hepatic lipogenesis. Biochem. J. 1994; 302: 141-6.
7. Knights KM, Drew R. The effects of ibuprofen enantiomers on hepatocyte intermediary metabolism and mitochondrial respiration. Biochem. Pharmacol. 1992; 44: 1291-6.
8. Yao KW, Mao LF, Luo MJ, Schulz H. The relationship between mitochondrial activation and toxicity of some substituted carboxylic acids. Chemico-Biol. Interact. 1994; 90: 225-34.
9. Sallustio BC, Meffin PJ, Knights KM. The stereospecific incorporation of fenoprofen into rat hepatocyte and adipocyte triacylglycerols. Biochem. Pharmacol. 1988; 37: 1919-23.
10. Moorhouse KG, Logan CJ, Hutson DH, Dodds PF. The incorporation of 3-phenoxybenzoic acid and other xenobiotic acids into xenobiotic lipids by enzymes of the monoacylglycerol pathway in microsomes from adult and neonatal tissues. Biochem. Pharmacol. 1990; 39: 1529-36.
11. Beinert H, Green DE, Hele P, Hift H, Von Korff RW, Ramakrishnan CV. The acetate activating system of heart muscle. J. Biol. Chem. 1953; 203: 35-45.
12. Groot PHE, Scholte HR, Hulsmann WC. Fatty acid activation: Specificity, localization and function. Adv. Lipid Res. 1976; 14: 75-126.
13. Imesch E, Rous S. Partial purification of rat liver cytoplasmic acetyl-CoA synthetase: Characterization of some properties. Int. J. Biochem. 1984; 16: 875-81.
14. Mahler HR, Wakil SJ, Bock RM. Studies on fatty acid oxidation. I. Enzymatic activation of fatty acids. J. Biol. Chem. 1953; 204: 453-68.
15. Killenberg PG, Davidson ED, Webster LT. Evidence for a medium-chain fatty acid:coenzyme A ligase (adenosine monophosphate) that activates salicylate. Mol. Pharmacol. 1971; 7: 260-8.
16. Groot PH. Acyl-CoA synthetases in guinea-pig liver mitochondria: Purification and characterization of a distinct propionyl-CoA synthetase. Biochem. Biophys. Acta 1976; 441: 260-7.
17. Altenschmidt U, Oswald B, Fuchs G. Purification and characterization of benzoate-coenzyme A ligase and 2-aminobenzoate-coenzyme A ligase from denitrifying Pseudomonas sp. J. Bacteriol. 1991; 173: 5494-501.
18. Miners JO, Grgurinovich N, Whitehead AG, Robson RA, Birkett DJ. Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. Br. J. Clin. Pharmacol. 1986; 22: 135-42.
19. Ponchaut S, Veitch K. Valproate and mitochondria. Biochem. Pharmacol. 1993; 46: 199-204.
20. Kornberg A, Pricer WE. Enzymatic synthesis of the coenzyme A derivatives of long chain fatty acids. J. Biol. Chem. 1953; 204: 329-43.
21. Tanaka T, Hosaka K, Hoshimaru M, Numa S. Purification and properties of long-chain acyl-coenzyme A synthetase from rat liver. Eur. J. Biochem. 1979; 98: 165-72.
22. Bronfman M, Inestrosa NC, Nervi FO, Leighton F. Acyl-CoA synthetase and the peroxisomal enzymes of β-oxidation in human liver. Biochem. J. 1984; 224: 709-20.
23. Berge RK, Vollset SE, Farstad M. Intracellular localization of palmitoyl-CoA hydrolase and palmitoyl-CoA synthetase in human blood platelets and liver. Scand. J. Clin. Lab. Invest. 1980; 40: 271-8.
24. Miyazawa S, Hashimoto T, Yokota S. Identity of long-chain acyl-coenzyme A synthetase of microsomes, mitochondria, and peroxisomes in rat liver. J. Biochem. 1985; 98: 723-33.
25. Davidson BC, Cantrill RC. Erythrocyte membrane acyl CoA synthetase activity. FEBS Lett. 1985; 193: 69-74.
26. Laposata M, Reich EL, Majerus PW. Arachidonoyl-CoA synthetase. Separation from nonspecific acyl-CoA synthetase and distribution in various cells and tissues. J. Biol. Chem. 1985; 260: 11 016-20.
27. Suzuki H, Kawarabayasi Y, Kondo J et al. Structure and regulation of rat long-chain acyl-CoA synthetase. J. Biol. Chem. 1990; 265: 8681-5.
28. Philip DP, Parsons P. Isolation and purification of long chain fatty acyl coenzyme A ligase from rat liver mitochondria. J. Biol. Chem. 1979; 254: 10 776-84.
29. Mishina M, Kamiryo T, Tashiro S, Numa S. Separation and characterization of two long-chain acyl-CoA synthetases from Candida lipolytica. Eur. J. Biochem. 1978; 82: 347-54.
30. Kono M, Hori C, Hashimoto T, Hori S, Seyama Y. Two distinct long-chain-acyl-CoA synthetases in guinea pig Harderian gland. Eur. J. Biochem. 1996; 238: 104-11.
31. Lazo O, Contreras M, Singh I. Topographical localization of peroxisomal acyl-CoA ligases: Differential localization of palmitoyl-CoA and lignoceroyl-CoA ligases. Biochemistry 1990; 29: 3981-6.
32. Mannaerts GP, Van Veldhoven P, Van Broekhoven A, Vandebroek G. Debeer LJ. Evidence that peroxisomal acyl-CoA synthetase is located at the cytoplasmic side of the peroxisomal membrane. Biochem. J. 1982; 204: 17-23.
33. Hesler CB, Olymbios C, Haldar D. Transverse-plane topography of long-chain acyl-CoA synthetase in the mitochondrial outer membrane. J. Biol. Chem. 1990; 265: 6600-5.
34. Bronfman M, Amigo L, Morales MN. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochem. J. 1986; 239: 781-4.
35. Bronfman M, Morales MN, Amigo L et al. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Detection of drug activation by human liver homogenates and by human platelets. Biochem. J. 1992; 284: 289-95.
36. Amigo L, McElroy MC, Morales MN, Bronfman M. Subcellular distribution and characteristics of ciprofibroyl-CoA synthetase in rat liver. Its possible identity with long-chain acyl-CoA synthetase. Biochem. J. 1992; 284: 283-7.
37. Aarsland A, Berge RK. Peroxisome proliferating sulphur- and oxysubstituted fatty acid analogues are activated to acyl coenzyme A thioesters. Biochem. Pharmacol. 1991; 41: 53-61.
38. Heuvel JPV, Kuslikis BI, Shragos E, Peterson RE. Inhibition of long-chain acyl-CoA synthetase by the peroxisome proliferator perfluorodecanoic acid in rat hepatocytes. Biochem. Pharmacol. 1991; 42: 295-302.
39. Imhof DA, Logan CJ, Dodds PF. Synthesis of 3-phenoxybenzoic acid containing lipids via the monoacylglycerol pathway. Biochem. Pharmacol 1985; 34: 3009-10.
40. Sanins SM, Adams WJ, Kaiser DG, Halstead GW, Hosley J, Barnes H, Baillie TA. Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat. Drug Metab. Dispos. 1991; 19: 405-10.
41. Knadler MP, Hall SD. Stereoselective arylpropionyl-CoA thioester formation in vitro. Chirality 1990; 2: 67-73.
42. Chen CS, Shieh WR, Lu PH, Harriman S, Chen CY. Metabolic stereoisomeric inversion of ibuprofen in mammals. Biochim. Biophys. Acta 1991; 1078: 411-17.
43. Knights KM, Addinall TF, Roberts BJ. Enhanced chiral inversion of R-ibuprofen in liver from rats treated with clofibric acid. Biochem. Pharmacol. 1991; 41: 1775-7.
44. Muller S, Mayer JM, Etter JC, Testa B. Influence of palmitate and benzoate on the unidirectional chiral inversion of ibuprofen in isolated rat hepatocytes. Biochem. Pharmacol. 1992; 44: 1468-70.
45. Knights KM, Jones ME. Inhibition kinetics of hepatic microsomal long-chain fatty acid-CoA ligase by 2-arylpropionic acid non-steroidal anti-inflammatory drugs. Biochem. Pharmacol. 1992; 43: 1465-71.
46. Knights KM, Talbot UM, Baillie TA. Evidence of multiple forms of rat liver microsomal coenzyme A ligase catalysing the formation of 2-arylpropionoyl-coenzyme A thioesters. Biochem. Pharmacol. 1992; 44: 2415-17.
47. Tracy TS, Wirthwein DP, Hall SD. Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl-coenzyme A. Drug Metab. Dispos. 1993; 21: 114-20.
48. Wechter WJ, Loughhead DG, Reischer RJ, VanGiessen GJ, Kaiser DG. Enzymatic inversion at saturated carbon: Nature and mechanism of the inversion of R(-)p-iso-butyl hydratropic acid. Biochem. Biophys. Res. Commun. 1974; 61: 833-7.
49. Nakamura Y, Yamaguchi T, Takahashi S, Hashimoto S, Iwatani K, Nakagawa Y. Optical isomerization mechanism of R(-)-hydratropic acid derivatives. J. Pharmacobio-Dynam. 1981; 4: S1.
50. Sanins SM, Adams WJ, Kaiser DG, Halstead GW, Baillie TA. Studies on the metabolism and chiral inversion of ibuprofen in isolated rat hepatocytes. Drug Metab. Dispos. 1990; 18: 527-33.
51. Williams KM, Knihinicki RD, Day RO. Pharmacokinetics of the enantiomers of ibuprofen in the rabbit. Agents Actions 1991; 34: 381-6.
52. Kaiser DG, Vangiessen GJ, Reischer RJ, Wechter WJ. Isomeric inversion of ibuprofen (R)-enantiomer in humans. J. Pharm. Sci. 1976; 65: 269-73.
53. Knihinicki RD, Williams KM, Day RO. Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs 1. In vitro studies of ibuprofen and flurbiprofen. Biochem. Pharmacol. 1989; 38: 4389-95.
54. Knights KM, Drew R, Meffin PJ. Enantiospecitic formation of fenoprofen coenzyme A thioester in vitro. Biochem. Pharmacol. 1988; 37: 3539-42.
55. Benoit E, Delatour P, Olivier L, Caldwell J. (-)-R-Fenoprofen: Formation of fenoprofenyl-coenzyme A by rat liver microsomes. Biochem. Pharmacol. 1995; 49: 1717-20.
56. Hall SD, Xiaotao Q. The role of coenzyme A in the biotransformation of 2-arylpropionic acids. Chemico-Biol. Interact. 1994; 90: 235-51.
57. Roberts BJ, Knights KM. Inhibition of rat peroxisomal palmitoyl-CoA ligase by xenobiotic carboxylic acids. Biochem. Pharmacol. 1992; 44: 261-7.
58. Roberts BJ, Knights KM. Differential induction of rat hepatic microsomal and peroxisomal long-chain and nafenopin-CoA ligases by clofibric acid and di-(2-ethylhexyl) phthalate. Xenobiotica 1995; 25: 469-76.
59. Roberts BJ, Macleod JK, Singh I, Knights KM. Kinetic characteristics of rat liver peroxisomal nafenopin-CoA ligase. Biochem. Pharmacol. 1995; 49: 1335-9.
60. Knights KM, Roberts BJ. Xenobiotic acyl-CoA formation: Evidence of kinetically distinct hepatic microsomal long-chain fatty acid and nafenopin-CoA ligases. Chemico-Biol. Interact. 1994; 90: 215-23.
61. Schoonjans K, Staels B, Grimaldi P, Auwerx J. Acyl-CoA synthetase mRNA expression is controlled by fibric acid derivatives, feeding and liver proliferation. Eur. J. Biochem. 1993; 216: 615-22.
62. Suzuki H, Watanabe M, Fujino T, Yamamoto T. Multiple promoters in rat acyl-CoA synthetase gene mediate differential expression of multiple transcripts with 5′-end heterogeneity. J. Biol. Chem. 1995; 270: 9676-82.
63. Schoonjans K, Watanabe M, Suzuki H et al. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J. Biol. Chem. 1995; 270: 19 269-76.
64. Abe T, Fujino T, Fukuyama R et al. Human long-chain acyl-CoA synthetase: Structure and chromosomal location. J. Biochem. 1992; 111: 123-8.
65. Ghosh B, Barbosa E, Singh I. Molecular cloning and sequencing of human palmitoyl-CoA ligase and its tissue specific expression. Mol. Cell. Biochem. 1995; 151: 77-81.
66. Garras A, Elholm M, Sleboda J, Froyland L, Osmundsen H, Berge RK. On the effects of thia fatty acid analogues on hydrolases involved in the degradation of metabolisable and non-metabolisable acyl-CoA esters. Xenobiotica 1997; 27: 781-99.
67. Orellana A, Hidalgo PC, Morales MN, Mezzano D, Bronfman M. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome-proliferator ciprofibrate potentiate diacylglycerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. Eur. J. Biochem. 1990; 190: 57-61.
68. Bjorge SM, Baillie TA. Studies on the β-oxidation of valproic acid in rat liver mitochondrial preparations. Drug Metab. Dispos. 1991; 19: 823-9.
69. Ruff LJ, Brass EP. Metabolic effects of pivalate in isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 1991; 110: 295-302.
70. Yoshida H, Kohno Y, Endo H et al. Mechanistic studies on metabolic chiral inversion of 4-(4-methylphenyl)-2-methylthiomethyl-4-oxobutanoic acid (KE-748), an active metabolite of the new anti-rheumatic agent 2-acetylthiomethyl-4-(4-methylphenyl)-4-oxobutanoic acid (KE-298), in rats. Biochem. Pharmacol. 1997; 53: 179-87.
71. Kiorpes TC, Hoerr D, Ho W, Weaner LE, Inman MG, Tutwiler GF. Identification of 2-tetradecylglycidyl coenzyme A as the active form of methyl 2-tetradecylglycidate (methyl palmoxirate) and its characterization as an irreversible, active site-directed inhibitor of carnitine palmitoyltransferase A in isolated rat liver mitochondria. J. Biol. Chem. 1984; 259: 9750-5.
72. Campbell L, Wilson HK, Samuel AM, Gompertz D. Interactions of m-xylene and aspirin metabolism in man. Br. J. Ind. Med. 1988; 45: 127-32.
73. Nishimaki-Mogami T, Tanaka A, Minegishi K, Takahashi A. Effect of sorbic acid feeding on peroxisomes and sorboyl-CoA metabolizing enzymes in mouse liver. Biochem. Pharmacol. 1991; 42: 239-46.
74. Sherratt HSA. Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit. Trends Pharmacol. Sci. 1986; 7: 186-91.
75. Shirley MA, Guan X, Kaiser DG, Halstead GW, Baillie TA. Taurine conjugation of ibuprofen in humans and in rat liver in vitro. Relationship to metabolic chiral inversion. J. Pharmacol. Exp. Ther. 1994; 269: 1166-75.